Related Experiment Video

Updated: Aug 29, 2026

Real-Time Assessment of Spinal Cord Microperfusion in a Porcine Model of Ischemia/Reperfusion
10:27

Real-Time Assessment of Spinal Cord Microperfusion in a Porcine Model of Ischemia/Reperfusion

Published on: December 10, 2020

The role of pharmacology in spinal cord protection during thoracic aortic reconstruction

T Brett Reece1, John A Kern, Curtis G Tribble

  • 1Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA 22908, USA.

Seminars in Thoracic and Cardiovascular Surgery
|January 8, 2004
PubMed

Insights

Minimizing neurologic complications during thoracic aorta surgery is crucial. This review explores spinal cord injury pathophysiology and investigational drugs for preventing these serious surgical risks.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Pharmacology

Background:

  • Thoracic aorta surgery carries a high risk of neurologic complications.
  • Current strategies to mitigate these risks are limited.
  • Pharmacologic neuroprotection remains an area of active research.

Purpose of the Study:

  • To review the pathophysiology of ischemic spinal cord injury.
  • To summarize investigational pharmacologic strategies for preventing neurologic complications in thoracic aorta surgery.

Main Methods:

  • Literature review of pathophysiology and pharmacology.
  • Synthesis of current research on neuroprotective agents.

Main Results:

  • Detailed explanation of ischemic spinal cord injury mechanisms.
  • Overview of several promising investigational drugs and their mechanisms of action.

Conclusions:

  • Understanding spinal cord injury pathophysiology is key to developing effective neuroprotection.
  • Further research into investigational pharmacology is essential for clinical application in thoracic aorta surgery.

More Related Videos

Spinal Cord Neurons Isolation and Culture from Neonatal Mice07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

Reproducible Motor Deficit Following Aortic Occlusion in a Rat Model Of Spinal Cord Ischemia08:10

Reproducible Motor Deficit Following Aortic Occlusion in a Rat Model Of Spinal Cord Ischemia

Published on: July 22, 2017

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...